Skip to main content
Lebrikizumab gets European nod for treating moderate-to-severe atopic dermatitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Lebrikizumab gets European nod for treating moderate-to-severe atopic dermatitis
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Europe
0
0.77
Atopic Dermatitis
0
0.99
Topical Corticosteroid
0
0.47
Corticosteroids
0
0.33
Ocular Allergy
0
0.32
Biologic Therapy
0
0.3
Conjunctivitis
0
0.3
Cornea and External Disease
0
0.3
Allergic Conjunctivitis
0
0.23
Dry Eye
0
0.15
Adolescent Medicine
0
0.11
Eczema
0
0.11
Interleukin
0
0.11
Monoclonal Antibody
0
0.11
Orbit
0
0.11
Severity Index
0
0.11
Topical Therapy
0
0.11
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
0.6
Family Medicine/Primary Care
0
0.8
Pediatrics
0
0.7
Internal Medicine
0
0.9
Pharmacist
0
0.5
Edit Tags